Microbial Secondary Metabolites: Targeting Tumors and Associated Challenges
Role of Microbes in Sustainable Development: Human Health and Diseases, Page: 429-439
2023
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Secondary metabolites derived from microbes have been utilized for a number of applications in the medical sector for a considerable time. Microbial secondary metabolites (MSMs) are utilized as enzyme inhibitors, immune-suppressants, hypocholesterolemic agents, etc., in the healthcare sector. Owing to their high efficacy and biocompatibility, several MSMs have also been applied for cancer treatment, responsible for major mortality in the world. Plenty of these metabolites are still under clinical trials awaiting large-scale application. This chapter summarizes the current status of tumor-targeting MSMs, recent innovations to elucidate the antitumor mechanism of these metabolites, and exploring potential microbes for the production of novel antitumor metabolites using co-cultivation and omics approaches.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85200185790&origin=inward; http://dx.doi.org/10.1007/978-981-99-3126-2_19; https://link.springer.com/10.1007/978-981-99-3126-2_19; https://dx.doi.org/10.1007/978-981-99-3126-2_19; https://link.springer.com/chapter/10.1007/978-981-99-3126-2_19
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know